Differences in MMP-2 Expression in High- and Low-Grade MPNST and its Correlation with Prognostic Factors

Niniek Hardini, Nurjati Chairani Siregar, Puspita Eka Wuyung

Abstract


Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma, which is difficult to distinguish from other spindle cell sarcomas. MPNST is hostile, with a high recurrence, and tends to metastasize hematogenously, especially to the lungs. A phase of the metastasis is a degradation of the extracellular matrix, where Matrix Metalloproteinase (MMP) plays an essential role in this process. Gelatinase-type MMP, MMP-2 and MMP-9, can degrade basal membrane and fibrillar collagen to open the invasion pathway. MMP-2 can degrade more collagen and non-collagen extracellular matrix than MMP-9. Therefore, the study aimed to see the relationship between MMP-2 overexpression and histopathological malignancy grading and other clinical prognostic variables. The study was conducted by immunohistochemical staining of MMP-2 in 39 cases, consisting of 19 cases of low-grade MPNST and 20 cases of high-grade MPNST. Subsequently, an analysis of the relationship between MMP-2 overexpression and the malignancy grading and clinical variables was performed, such as age, sex, and tumor size and location. MMP-2 overexpression was seen in 19 (95%) cases of high grade and three (15.8%) cases of low-grade MPNST (p 0.000). The study also found a significant relationship between MMP-2 overexpression and histopathology grading, which may be helpful to define the prognosis.

Keywords


MMP-2; low-grade MPNST and high-grade MPNST; prognostic factors

Full Text:

PDF

References


Kar M, Deo SVS, Shukla NK, Malik A, Gupta SD, Mohanti BK, et al. Malignant Peripheral Nerve Sheath Tumors (MPNST)- Clinicopathological Study and Treatment Outcome of Twenty-four Cases. World J Surg Oncol. 2006; 4: 55. https://doi.org/10.1186/1477-7819-4-55

Fletcher CDM, Gronchi A. Tumours of Soft Tissue: Introduction. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. World Health Organization Classification of Tumours of Soft Tissue and Bone. Lyon: IARC; 2013. p.14-8.

Srinivas SP, Rao L, Nayak DR. Widely Infiltrating Epiteloid Malignant Peripheral Nerve Sheath Tumors of Skull Base. Malays J Med Sci. 2013; 20: 82-5.

Al Gharibi KN. MMP Family Protein Expression as Prognostic Biomarkers in Human Soft Tissue Sarcoma of Extremities [Ph.D. Thesis]. UK: University of Manchester; 2012. [cited 2014 April 9].

Koga K, Nabeshima K, Aoki M, Kawakami T, Hamasaki M, Toole BP et al. EMMPRIN in Epitheloid Sarcoma: Expression in Tumor Cell Membrane and Stimulation of MMP-2 Production in Tumor-Associated Fibroblasts. Int J Cancer. 2006; 120; 761-8. https://doi.org/10.1002/ijc.22412

Kahari VM, Reunanen N. Matrix Metalloproteinases in Cancer Cell Invasion. In: Kahari VM, Heino J, editors. Cell Invasion. Texas: Eurekah; 2002. p. 1-11.

Nagase H, Visse R. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function and Biochemistry. Circ Res. 2003; 92: 827-39. https://doi.org/10.1161/01.RES.0000070112.80711.3D

Nelson AR, Fingleton B, Rothenberg M, Matrisian LM. Matrix Metalloproteinases: Biologic Activity and Clinical Implication. J Clin Oncol. 2000; 18: 1135-49. https://doi.org/0.1200/JCO.2000.18.5.1135

Giavazzi R, Garofalo A, Ferri C, Lucchini V, Bone EA, Chari S et al. Batimastat, a synthetic inhibitor of matrix metalloproteinases potentiates the antitumor activity of cisplastin in ovarian carcinoma xenografts. Clinic Cancer Res. 1998:4:985-92.

Botos I, Scapozza L, Zhang D, Liotta L, Meyer EF. Batimastat, a Potent Matrix Metalloproteinase Inhibitor, Exhibits an Unexpected Mode of Binding. Proc Natl Acad Sci. 1996: 93: 2749-54. https://doi.org/10.1073/pnas.93.7.2749

Hojilla CV, Mohammed FF, Khokha R. Matrix Metalloproteinases and Their Tissue Inhibitors Direct Cell Fate during Cancer Development. Br J Cancer. 2003; 89: 1817-21. https://doi.org/10.1038/sj.bjc.6601327

Schmidt RF, Yick F, Boghani Z, Eloy JA, Liu JK. Malignant Peripheral Nerve Sheath Tumors of the Trigeminal Nerve: a Systematic Review of 36 Cases. Neurosurg Focus. 2013; 34.

Abdul KFW, Antonescu CU, Dal Cin P, Folpe AL, Geisinger KM, Gown AM, et al. Malignant Tumors of the Peripheral Nerves, in: Weiss SW, Goldblum JR, eds. Soft Tissue Tumors. Mosby: Elsiever; 2008. 903-44.

Stasik CJ, Tawfik O. Malignant Peripheral Nerve Sheath Tumor with Rhabdomyosarkomatous Differentiation (Malignant Triton Tumor). Arch Pathol Lab Med. 2006;130: 1878-80. https://doi.org/10.5858/2006-130-1878-MPNSTW

Friedrich RE, Hartmann M, Mautner VF. Malignant Peripheral Nerve Sheath Tumors (MPNST) in NF1-Affected Children. Anticancer Res. 2007; 27: 1957-60.

Fisher C, Montgomery EA, Thway K. Spindle cell sarkomas. In: Epstein JI, eds. Biopsy Interpretation of Soft Tissue Tumors. Wolters Kluwer: Lippincott Williams & Wilkins; 2011. 195-207.

Porter DE, Prasad V, Loster L, Dall GF, Birch R, Grimer RJ. Survival in Malignant Peripheral Nerve Sheath Tumors: a Comparison between Sporadic and Neurofibromatosis Type 1-associated Tumors. Sarcoma. 2009;10.

Nielsen G.P, Antonescu C.R, Lothe R.A. Malignant Peripheral Nerve Sheath Tumour. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, eds. World Health Organization Classification of Tumours of Soft Tissue and Bone. Lyon: IARC; 2013. 187-9. https://doi.org/10.1177/1066896917709580

Stucky CH, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS et al. Malignant Peripheral Nerve Sheath Tumor (MPNST): The Mayo Clinic Experience. Ann Surg Oncol. 2012:19: 878-85. https://doi.org/10.1245/s10434-011-1978-7

Abdul KFW, Antonescu CU, Dal Cin P, Folpe AL, Geisinger KM, Gown AM, et al. General Consideration. In: Weiss SW, Goldblum JR, eds. Soft Tissue Tumors. Mosby: Elsevier; 2008.1-14.

Alford SH, Vrana MS, Waite L, Heim-Hall J, Sylvia VL, Williams RP. Matrix Metalloproteinase Expression in High Degree Soft Tissue Sarcomas. Oncol Rep. 2003; 18; 1529-36.

Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C. Malignant Peripheral Nerve Sheath Tumors. Cancer. 2006; 107: 1065-74. https://doi.org/10.1002/cncr.22098

Guo A, Liu A, Wei L, Song X. Malignant Peripheral Nerve Sheath Tumors: Differentiation Patterns and Immunohistochemical Features- a Mini Review and Our New Findings. J Cancer. 2012: 3: 303-9. https://doi.org/10.7150/jca.4179

Coindre JM. Grading of Soft Tissue Sarcoma: Review and Update. Arch Pathol Lab Med. 2006: 130: 1448-53. https://doi.org/10.5858/2006-130-1448-GOSTSR

Grimer RJ. Size Matters for Sarcomas. Ann R Coll Surg Engl; 2006: 88: 519-24. https://doi.org/10.1308/003588406X130651

Minovi A, Basten O, Hunter B, Draf W, Bockmuhl U. Malignant Peripheral Nerve Sheath Tumors of the Head and Neck: Management of 10 Cases and Literature Review. Wiley Periodicals, Inc. Head Neck. 2006; 29: 439-45. https://doi.org/10.1002/hed.20537

Benassi MS, Gamberi G, Magagnoli G, Molendini L, Ragazzini P, Merli M, et al. Metalloproteinase Expression and Prognosis in Soft Tissue Sarcomas. Ann Oncol. 2001; 75-80. https://doi.org/10.1023/a:1008318614461

Aydin MD, Yildirim U, Gundogdu C, Dursun O, Uysul HH, Ozdikici M. Malignant Peripheral Nerve Sheath Tumor of the Orbit: Case Report and Literature Review. Skull Base. 2004;14:109-13. https://doi.org/10.1055/s-2004-828705

Yang HK, Jeong KC, Kim YK, Jung SK. Role of Matrix Metalloproteinases (MMP)2 and MMP-9 in Soft Tissue Sarcoma. Clinic Orthoped Surg. 2014; 6: 443-54. https://doi.org/10.4055/cios.2014.6.4.443




DOI: https://doi.org/10.18196/mmjkk.v21i2.10882

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

      

Editorial Office:
Journal Room, G1 (Biomedic) Building, Ground Floor, Faculty of Medicine and Health Science Universitas Muhammadiyah Yogyakarta, 
Jalan Lingkar Selatan (Brawijaya), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia
Phone: +62 274 387 656 (ext: 231)
WA : +62 811-2650-303
Website: http://journal.umy.ac.id/index.php/mm 
E-mail: mmjkk@umy.university

Creative Commons License
Mutiara Medika: Jurnal Kedokteran dan Kesehatan is licensed under a Creative Commons Attribution 4.0 International License. View My Stats